相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tu1303 Risk of Surgery Following Diagnosis in Adult and Pediatric Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis
Maria E. Negron et al.
GASTROENTEROLOGY (2015)
Mesalamine Dose Escalation Reduces Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
Mark T. Osterman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Fecal Level of Calprotectin Identifies Histologic Inflammation in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission
Jordi Guardiola et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial
Laurent Peyrin-Biroulet et al.
GUT (2014)
Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC
Marc Ferrante et al.
GASTROENTEROLOGY (2013)
Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2013)
C-reactive protein, an indicator for maintained response or remission to infliximab in patients with Crohn's disease: a post-hoc analysis from ACCENT I
W. Reinisch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Surgery in a Population-Based Cohort of Crohn's Disease From Olmsted County, Minnesota (1970-2004)
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
Geert D'Haens et al.
INFLAMMATORY BOWEL DISEASES (2012)
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naive patients with ulcerative colitis
M. De Vos et al.
JOURNAL OF CROHNS & COLITIS (2012)
Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease
Clas-Goran af Bjorkesten et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Dosage Adjustment During Long-term Adalimumab Treatment for Crohn's Disease: Clinical Efficacy and Pharmacoeconomics
William J. Sandborn et al.
INFLAMMATORY BOWEL DISEASES (2011)
Development of the Crohn's Disease Digestive Damage Score, the Lemann Score
Benjamin Pariente et al.
INFLAMMATORY BOWEL DISEASES (2011)
Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes, and the CDAI
Alain M. Schoepfer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Correlation Between the Crohn's Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn's Disease Severity
Severine Vermeire et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Filip Baert et al.
GASTROENTEROLOGY (2010)
E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided 'Constant-care' approach
Margarita Elkjaer et al.
GUT (2010)
Endoscopic Evaluation of Crohn's Disease Activity: Comparison of the CDEIS and the SES-CD
Taina Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2010)
W1165 Clinical Assessment of Ulcerative Colitis Activity Correlates Poorly with Endoscopic Disease Activity.
Joseph F. Rodemann et al.
GASTROENTEROLOGY (2009)
Factors Predicting the Outcome of Disease Activity Assessment in Crohn's Disease
Henrik Stjernman et al.
INFLAMMATORY BOWEL DISEASES (2009)
Ulcerative Colitis: Correlation of the Rachmilewitz Endoscopic Activity Index with Fecal Calprotectin, Clinical Activity, C-reactive Protein, and Blood Leukocytes
Alain M. Schoepfer et al.
INFLAMMATORY BOWEL DISEASES (2009)
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: Performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices
Jost Langhorst et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohn's disease activity index and endoscopic findings
Toino Sipponen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease
Michael Wagner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Fecal calprotectin:: A quantitative marker of colonic inflammation in children with inflammatory bowel disease
Ulrika Lorentzon Fagerberg et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
Assessment of endoscopic activity lndex and biological lnflammatory markers in clinically active Crohn's disease with normal C-reactive protein serum level
Marie-Arrhelle Denis et al.
INFLAMMATORY BOWEL DISEASES (2007)
Predicting the Crohn's disease activity index from the Harvey-Bradshaw index
WR Best
INFLAMMATORY BOWEL DISEASES (2006)
Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease
CA Solem et al.
INFLAMMATORY BOWEL DISEASES (2005)
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease
F Costa et al.
GUT (2005)
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
M Daperno et al.
GASTROINTESTINAL ENDOSCOPY (2004)
分享论文
